CN111662287B - Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester - Google Patents

Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester Download PDF

Info

Publication number
CN111662287B
CN111662287B CN202010428368.3A CN202010428368A CN111662287B CN 111662287 B CN111662287 B CN 111662287B CN 202010428368 A CN202010428368 A CN 202010428368A CN 111662287 B CN111662287 B CN 111662287B
Authority
CN
China
Prior art keywords
ethyl
compound
methyl
dihydro
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010428368.3A
Other languages
Chinese (zh)
Other versions
CN111662287A (en
Inventor
张大为
周强
高明飞
姚宝元
兰倩倩
赵廷
王曦
卫维
魏昕睿
谭汝鹏
贾涛
白有银
孙春
付新雨
于凌波
马汝建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuxi STA Pharmaceutical Co Ltd
Original Assignee
Wuxi STA Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi STA Pharmaceutical Co Ltd filed Critical Wuxi STA Pharmaceutical Co Ltd
Priority to CN202010428368.3A priority Critical patent/CN111662287B/en
Publication of CN111662287A publication Critical patent/CN111662287A/en
Application granted granted Critical
Publication of CN111662287B publication Critical patent/CN111662287B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a preparation method of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformate, which mainly solves the technical problem that no industrial synthesis method is available at present. The invention is divided into three steps, the third stepFirstly, reacting a compound 1 in hydrochloric acid to obtain a compound 2, secondly, reacting the compound 2 with ethyl glyoxylate toluene solution in acetonitrile to obtain a compound 3, and thirdly, reacting the compound 3 with Boc anhydride and triethylamine in dichloromethane to obtain a final compound 4, wherein the reaction formula is as follows:

Description

Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester
Technical Field
The invention relates to a synthesis method of a compound 5-tert-butyl-4-ethyl-3-methyl-6, 7-dihydro-3H-imidazo [4,5-C ] pyridine-4, 5(4H) -diformyl ester, which is abbreviated as: preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester.
Background
The compound 5-tert-butyl-4-ethyl-3-methyl-6, 7-dihydro-3H-imidazo [4,5-C ] pyridine-4, 5(4H) -diformyl ester (CAS: 1380679-97-9) and related derivatives have wide application in pharmaceutical chemistry and organic synthesis. At present, the synthesis method of 5-tert-butyl-4-ethyl-3-methyl-6, 7-dihydro-3H-imidazo [4,5-C ] pyridine-4, 5(4H) -diformyl ester is only reported in documents. Therefore, it is necessary to develop a synthesis method which has easily available raw materials, convenient operation, easy control of reaction, proper overall yield and suitability for industrial production.
Disclosure of Invention
The invention aims to develop a synthetic method of 5-tert-butyl-4-ethyl-3-methyl-6, 7-dihydro-3H-imidazo [4,5-C ] pyridine-4, 5(4H) -diformyl ester, which has the advantages of easily obtained raw materials, convenient operation, easily controlled reaction and higher yield. Mainly solves the technical problem that no industrial synthesis method is available at present.
The technical scheme of the invention is as follows: the invention relates to a synthesis method of 5-tert-butyl-4-ethyl-3-methyl-6, 7-dihydro-3H-imidazo [4,5-C ] pyridine-4, 5(4H) -diformate, which comprises three steps, wherein the first step is to react a compound 1 in hydrochloric acid to obtain a compound 2, the second step is to react the compound 2 with ethyl glyoxylate toluene solution in acetonitrile to obtain a compound 3, and the third step is to react the compound 3 with Boc anhydride and triethylamine in dichloromethane to obtain a final compound 4, wherein the reaction formula is as follows:
Figure 389904DEST_PATH_IMAGE002
the first step of reaction is carried out in 6N hydrochloric acid at the temperature of reflux (100 ℃) for 25 hours; the second step is that the mass percentage concentration of the ethyl glyoxylate in the toluene is 50 percent, the reaction temperature is 80 ℃, and the reaction time is 7 hours; the third step is carried out at room temperature overnight.
The invention discloses an abbreviated Chinese meaning: TLC: thin layer chromatography.
The invention has the beneficial effects that: the reaction process is reasonable in design, adopts easily-obtained and large-scale-production raw material 2-methyl-5-oxylidene-5, 6,7, 8-tetrahydroimidazo [1,5-C ] pyrimidine-2-iodide positive ions, and synthesizes 5-tert-butyl-4-ethyl-3-methyl-6, 7-dihydro-3H-imidazo [4,5-C ] pyridine-4, 5(4H) -diformate through three steps.
Detailed Description
The reaction formula of the invention is as follows:
Figure 369362DEST_PATH_IMAGE004
example (b):
the first step is as follows: compound 1 (569 g, 2.0 mol) was dissolved in 6N hydrochloric acid (5.0L) and stirred at 100 ℃ reflux temperature for 25 hours. TLC (dichloromethane/methanol volume ratio = 10/1) indicated complete consumption of the starting material and concentration of the solvent under reduced pressure gave compound 2 as a yellow solid (235 g, yield: 62%).
1(400 M; D2O)
δ 8.59 (s, 1H), 7.33 (s, 1H), 3.83 (s, 3H), 3.29 (t, J = 7.2 Hz, 2H), 3.08 (t, J = 7.2 Hz, 2H)。
The second step is that: compound 2 (243 g, 1.5 mol) was dissolved in acetonitrile (2.5L), ethyl glyoxylate (50% by weight in toluene, 1.5 mol) was added, the mixture was heated to 80 ℃ under reflux, and stirring was continued for 7 hours. TLC (dichloromethane/methanol volume ratio = 10/1) showed complete reaction of the starting material and the solvent was removed under reduced pressure to yield compound 3 as a yellow solid (157 g, 50% yield).
1(400 M; D2O)
δ 8.73 (s, 1H), 5.74 (s, 1H), 4.28 (dd, 2H), 3.88 (s, 3H), 3.79 (dd, 1H), 3.56 (dd, 1H), 3.02 (dd, 2H), 1.21 (t, J = 7.2 Hz, 3H)。
The third step: compound 3 (194 g, 0.93 mol) and triethylamine (188 g, 1.86 mol) were dissolved in anhydrous dichloromethane (2.0L), Boc anhydride (203 g, 0.93 mol) was added dropwise at 0 deg.C, and stirred at room temperature 25 deg.C overnight for 12 hours. TLC (petroleum ether/ethyl acetate volume ratio = 1/1) showed the starting material was completely reacted. The reaction solution was washed with water (500 mL × 4), and the organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography to give compound 4 (138 g, yield: 48%) as a colorless oil.
1(400 M; CDCl3)
δ 7.34 (s, 1H), 5.68 (s, 1H), 4.20 (dd, 2H), 4.18 (dd, 2H), 3.68 (s, 3H), 3.29 (dd, 1H), 2.65 (dd, 2H), 1.46 (s, 9H), 1.24 (t, 3H)。

Claims (6)

1. A preparation method of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester is characterized in that: the method comprises the following steps of firstly reacting a compound 1 in hydrochloric acid to obtain a compound 2, secondly reacting the compound 2 with ethyl glyoxylate toluene solution in acetonitrile to obtain a compound 3, and thirdly reacting the compound 3 with Boc anhydride and triethylamine in dichloromethane to obtain a final compound 4, wherein the reaction formula is as follows:
Figure 232678DEST_PATH_IMAGE002
2. the process for producing 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformate according to claim 1, wherein: the first reaction step was carried out in 6N hydrochloric acid.
3. The process for producing 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester according to claim 1, wherein: the first step is maintained at 100 ℃ and the reaction is carried out for 25 hours.
4. The process for producing 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformate according to claim 1, wherein: the mass percentage concentration of the ethyl glyoxylate in the toluene in the second step is 50 percent.
5. The process for producing 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformate according to claim 1, wherein: the second step reaction temperature was 80 ℃ and the reaction time was 7 hours.
6. The process for producing 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformate according to claim 1, wherein: and the third step is carried out at room temperature overnight.
CN202010428368.3A 2020-05-20 2020-05-20 Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester Active CN111662287B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010428368.3A CN111662287B (en) 2020-05-20 2020-05-20 Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010428368.3A CN111662287B (en) 2020-05-20 2020-05-20 Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester

Publications (2)

Publication Number Publication Date
CN111662287A CN111662287A (en) 2020-09-15
CN111662287B true CN111662287B (en) 2022-05-17

Family

ID=72384146

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010428368.3A Active CN111662287B (en) 2020-05-20 2020-05-20 Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester

Country Status (1)

Country Link
CN (1) CN111662287B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107312007B (en) * 2017-06-29 2019-04-30 上海合全药业股份有限公司 The preparation method of 2 (2- ethyoxyl -2- oxoethyl) -8- methyl -5,6- glyoxalidine and the pyrazine carboxylic acid tert-butyl ester
CN108033966A (en) * 2018-01-05 2018-05-15 天津药明康德新药开发有限公司 The synthetic method of 5,6 dihydro Triazolopyrazine 3,7 (8H) dioctyl phthalate base ester of 7- tert-butyl group 3- ethyl 8- methyl

Also Published As

Publication number Publication date
CN111662287A (en) 2020-09-15

Similar Documents

Publication Publication Date Title
CN111620869B (en) Synthesis method of tert-butyl-1, 7-diazaspiro [3.5] nonane-1-formyloxy ester
CN107501112B (en) A kind of Chiral Synthesis of chiral beta-amino acids and the synthetic method of medicine intermediate
CN111777571B (en) Synthesis method of chiral 2-amino-3- (1, 3-benzothiazole-2-yl) propionic acid hydrochloride
CN112645833A (en) Synthesis method of (S) -2, 6-diamino-5-oxohexanoic acid
CN111533745A (en) Process for preparing tert-butyl-3- (aminomethyl) dihydro-5H-triazolodiazepine-8 (9H) -carboxylic acid ester
CN111662245A (en) Synthesis method of ethyl-3-oxylidene-1-oxa-4-azaspiro [5.5] undecane-9-formic acid ester
CN111662287B (en) Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester
JPH06172256A (en) Production of 3-hydroxybutyric acid derivative
CN110551123A (en) Preparation method of 5- (tert-butyloxycarbonyl) -2-methyl-4, 5,6, 7-tetrahydro-2H-pyrazolo [4,3-C ] pyridine-7-carboxylic acid
CN110563726A (en) Preparation method of tert-butyl-7, 9-dioxy-2, 6-diazaspiro [4.5] decane-2-formic acid ester
CN111548356B (en) Process for preparing tert-butyl-1, 8-dioxa-4, 11-diazaspiro [5.6] dodecane-11-carboxylic acid ester
CN111574524B (en) 2- (tert-butoxycarbonyl) -7-oxyylidene-2, 6-diazaspiro [3.4] octane-5-carboxylic acid preparation method
CN111943870A (en) Synthesis method of L-2- (9H-fluorene-9-methoxycarbonylamino) -3-iodopropionic acid methyl ester
CN111533752A (en) Preparation method of tert-butyl-7-bromo-5-oxa-2-azaspiro [3.4] octane-2-formic acid ester
CN110627686A (en) Synthesis method of fluorenylmethyloxycarbonyl-O-trityl-L-threonine
CN111606905B (en) Preparation of di-tert-butyl-2- (2-ethoxy-2-oxoethylidene) dihydro-3H-imidazopyridine diformate
CN111620877B (en) Process for preparing 1-benzyl-5- (tert-butyloxycarbonyl) octahydropyrrolopyrrole-2-carboxylic acid
CN110563687B (en) Preparation method of 4- (aminomethyl) chroman-3-ol
CN111533740A (en) Process for preparing tert-butyl-1- (hydroxymethyl) -3-oxoidene-2, 8-diazaspiro [4.5] decane formylic ester
CN115433097B (en) Method for preparing 4-butoxybenzoic acid (2-diethylaminoethyl) ester without metal
CN110551129B (en) Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester
CN110483534B (en) Preparation method of (2,4,5, 7-tetrahydropyrano [3,4-c ] pyrazol-7-yl) methanol
CN115677639B (en) Preparation method of tetrahydro-3-oxo-2H-pyran-4-carboxylic acid methyl ester intermediate
CN109912521B (en) Method for synthesizing alkenyl-substituted 1,2, 3-triazole derivative in one step
CN110563723A (en) Preparation method of 6-bromo-3- (piperidine-4-yl) imidazo [1,2-a ] pyridine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant